Skip to main
TNMG
TNMG logo

TNL Mediagene (TNMG) Stock Forecast & Price Target

TNL Mediagene (TNMG) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TNL Mediagene has demonstrated a robust performance, achieving a notable 35% year-over-year revenue increase in FY24, driven by momentum across its core business segments. The company's media networks are increasingly attractive to brands and agencies, enhancing their potential to capture larger shares of advertising budgets through improved targeting and return on investment. Additionally, the presence of an active M&A pipeline suggests that inorganic growth strategies could sustain an annual revenue growth rate of 25-30% over the next 3-4 years.

Bears say

TNL Mediagene faces significant risks due to potential missteps in market entry and mergers and acquisitions, which could severely disrupt growth and erode shareholder value. Additionally, the company may fall behind its more technologically adept competitors if it fails to adapt to or invest in essential AI capabilities, compromising its competitive position in the digital advertising space. Lastly, as a recently listed SPAC, TNL Mediagene's lack of a meaningful public track record raises concerns regarding management's execution capabilities, creating near-term risks related to visibility and investor confidence.

TNL Mediagene (TNMG) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TNL Mediagene and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TNL Mediagene (TNMG) Forecast

Analysts have given TNL Mediagene (TNMG) a Buy based on their latest research and market trends.

According to 1 analysts, TNL Mediagene (TNMG) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TNL Mediagene (TNMG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.